In head and neck squamous cell carcinoma (HNSCC), the overexpression of let-7a/b miRNAs in combination with CTLA-4 antibody promotes anticancer immunity by accelerating PD-L1 degradation [129]. The gene discussed is CTLA4; the disease is head and neck squamous cell carcinoma.